Literature DB >> 34372804

Silicate/zinc-substituted strontium apatite coating improves the osteoinductive properties of β-tricalcium phosphate bone graft substitute.

Hironori Sugimoto1, Yusuke Inagaki2, Akira Furukawa1, Tsutomu Kira1, Sachiko Kawasaki1, Yoshinobu Uchihara1, Manabu Akahane3, Yasuhito Tanaka1.   

Abstract

BACKGROUND: β-Tricalcium phosphate-TCP) is a popular synthetic bone graft substitute with excellent osteoconductive properties and bioabsorbability. However, its osteoinductive properties are inferior to those of autologous or allogeneic bone. Trace elements such as strontium (Sr), silica (Si), and zinc (Zn) have been reported to promote osteogenesis in materials. In this study, we aimed to determine whether a Si/Zn-substituted Sr apatite coating of β-TCP could enhance osteoinductive properties.
METHODS: The apatite-coated β-TCP disks were prepared using nanoparticle suspensions of silicate-substituted Sr apatite (SrSiP) or silicate- and Zn-co-substituted Sr apatite (SrZnSiP). Bone marrow mesenchymal cells (BMSCs) from rat femur were cultured and subsequently seeded at a density of 1.0 × 106/cm2 onto apatite-coated and non-coated β-TCP disks. In vitro, the β-TCP disks were then placed in osteogenic medium, and lactate dehydrogenase (LDH) activity was measured from supernatants after culture for 2 days. Additionally, after culture for 14 days, the mRNA expression of genes encoding osteocalcin (OC), alkaline phosphatase (ALP), bone morphogenetic protein-2 (BMP-2), and vascular endothelial growth factor (VEGF) was evaluated by qRT-PCR. In vivo, the β-TCP disks were transplanted subcutaneously into rats that were sacrificed after 4 weeks. Then, the harvested disks were evaluated biochemically (ALP activity, OC content, mRNA expression of OC, ALP, BMP-2, and VEGF measured by qRT-PCR), radiologically, and histologically.
RESULTS: Significantly higher mRNA expression of almost all evaluated osteogenic and angiogenic genes was observed in the SrZnSiP and SrSiP groups than in the non-coated group, with no significant cytotoxicity elicited by the apatite coating in vitro. Moreover, in vivo, the SrZnSiP and SrSiP groups showed significantly higher osteogenic and angiogenic gene expression and higher ALP activity and OC content than the non-coated group (P < 0.05). Radiological and histopathological findings revealed abundant bone formation in the apatite-coated group.
CONCLUSIONS: Our findings indicate that apatite coating of β-TCP improves osteoinductive properties without inducing significant cytotoxicity.
© 2021. The Author(s).

Entities:  

Keywords:  apatite coating; bone graft substitute; trace elements; β-tricalcium phosphate

Year:  2021        PMID: 34372804     DOI: 10.1186/s12891-021-04563-4

Source DB:  PubMed          Journal:  BMC Musculoskelet Disord        ISSN: 1471-2474            Impact factor:   2.362


  39 in total

1.  Long-term clinical outcomes following the use of synthetic hydroxyapatite and bone graft in impaction in revision hip arthroplasty.

Authors:  Tajeshwar S Aulakh; Narlaka Jayasekera; Jan-Herman Kuiper; James B Richardson
Journal:  Biomaterials       Date:  2009-01-10       Impact factor: 12.479

2.  In vitro stability of open wedge high tibial osteotomy with synthetic bone graft.

Authors:  Ryohei Takeuchi; Haruhiko Bito; Yasushi Akamatsu; Toshihiko Shiraishi; Shin Morishita; Tomihisa Koshino; Tomoyuki Saito
Journal:  Knee       Date:  2009-10-04       Impact factor: 2.199

3.  Tissue-engineered approach for the treatment of steroid-induced osteonecrosis of the femoral head: transplantation of autologous mesenchymal stem cells cultured with beta-tricalcium phosphate ceramics and free vascularized fibula.

Authors:  Kenji Kawate; Hiroshi Yajima; Hajime Ohgushi; Noriko Kotobuki; Kazuya Sugimoto; Tetsuji Ohmura; Yasunori Kobata; Koji Shigematsu; Kenji Kawamura; Katsuya Tamai; Yoshinori Takakura
Journal:  Artif Organs       Date:  2006-12       Impact factor: 3.094

4.  Utility of tricalcium phosphate and osteogenic matrix cell sheet constructs for bone defect reconstruction.

Authors:  Tomoyuki Ueha; Manabu Akahane; Takamasa Shimizu; Yoshinobu Uchihara; Yusuke Morita; Naoya Nitta; Akira Kido; Yusuke Inagaki; Kenji Kawate; Yasuhito Tanaka
Journal:  World J Stem Cells       Date:  2015-06-26       Impact factor: 5.326

5.  Comparison of in vivo bioactivity and compressive strength of a novel superporous hydroxyapatite with beta-tricalcium phosphates.

Authors:  Yusuke Okanoue; Masahiko Ikeuchi; Ryuichi Takemasa; Toshikazu Tani; Toshio Matsumoto; Michiko Sakamoto; Masanori Nakasu
Journal:  Arch Orthop Trauma Surg       Date:  2012-07-04       Impact factor: 3.067

6.  Scaffold-free cell sheet injection results in bone formation.

Authors:  Manabu Akahane; Hideki Shigematsu; Mika Tadokoro; Tomoyuki Ueha; Tomohiro Matsumoto; Yasuaki Tohma; Akira Kido; Tomoaki Imamura; Yasuhito Tanaka
Journal:  J Tissue Eng Regen Med       Date:  2010-07       Impact factor: 3.963

7.  The outcome of biphasic calcium phosphate bone substitute in a medial opening wedge high tibial osteotomy.

Authors:  Sven Putnis; Thomas Neri; Antonio Klasan; Myles Coolican
Journal:  J Mater Sci Mater Med       Date:  2020-05-28       Impact factor: 3.896

Review 8.  Bone grafts, bone substitutes and orthobiologics: the bridge between basic science and clinical advancements in fracture healing.

Authors:  Timothy T Roberts; Andrew J Rosenbaum
Journal:  Organogenesis       Date:  2012-10-01       Impact factor: 2.500

9.  Bone formation and resorption in patients after implantation of beta-tricalcium phosphate blocks with 60% and 75% porosity in opening-wedge high tibial osteotomy.

Authors:  Takaaki Tanaka; Yoshio Kumagae; Mitsuru Saito; Masaaki Chazono; Hirokazu Komaki; Takahiro Kikuchi; Seiichiro Kitasato; Keishi Marumo
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2008-08       Impact factor: 3.368

10.  Bone regeneration with osteogenic matrix cell sheet and tricalcium phosphate: An experimental study in sheep.

Authors:  Tsutomu Kira; Manabu Akahane; Shohei Omokawa; Takamasa Shimizu; Kenji Kawate; Tadanobu Onishi; Yasuhito Tanaka
Journal:  World J Orthop       Date:  2017-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.